This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Bacterial Infections  • Pneumonia  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

Madhavi Bollu, MD; Andres Marte-Grau, MD; Ravi K. Bobba, MD

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We commend Thomsen and colleagues¹ for their article about the preadmission use of statins in patients with pneumonia. As discussed by the authors, this article addresses the increasingly recognized role of statins in infectious process.

In a review of Medicare patients older than 65 years, Houck et al² found that administering antibiotics within 4 hours of the patients' arrival resulted in a decrease of mortality and length of stay. In the United States, we follow these guidelines when treating patients with pneumonia. Since the authors did not mention the timing of antibiotic use once a patient is evaluated by a physician, we would like to know if this was included in the analysis.

In a study by Frost et al,³ a statin dose dependence was observed in the reduction of mortality in influenza and chronic obstructive pulmonary disease cases. In . . . [Full Text of this Article]

AUTHOR INFORMATION


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Preadmission Use of Statins and Outcomes After Hospitalization With Pneumonia: Population-Based Cohort Study of 29 900 Patients
Reimar W. Thomsen, Anders Riis, Jette B. Kornum, Steffen Christensen, Søren P. Johnsen, and Henrik T. Sørensen
Arch Intern Med. 2008;168(19):2081-2087.
ABSTRACT | FULL TEXT